Citation:Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P 2011

From Cancer Guidelines Wiki

Citation


Hvid-Jensen F, Pedersen L, Drewes AM, Sørensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011 Oct 13;365(15):1375-83 Available from: http://www.ncbi.nlm.nih.gov/pubmed/21995385.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the incidence of neoplasia in patients with BO?Associate Professor Freddy Sitascompleted
What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?David Whitemancompleted
Are there groups of patients with non-dysplastic BO that require more frequent surveillance?Dr Henry Tocompleted
Are there groups of patients with BO that can be discharged from surveillance?Conjoint Associate Professor Philip Craigcompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the incidence of neoplasia in patients with BO?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the incidence of neoplasia in patients with BO?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Are there groups of patients with non-dysplastic BO that require more frequent surveillance?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Are there groups of patients with non-dysplastic BO that require more frequent surveillance?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:Are there groups of patients with BO that can be discharged from surveillance?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:Are there groups of patients with BO that can be discharged from surveillance?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. Are there groups of patients with non-dysplastic BO that require more frequent surveillance?
  2. Is surveillance cost-effective for follow-up of patients with BO?
  3. What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?
  4. What is the incidence of neoplasia in patients with BO?